[A new method for the treatment of depression: repetitive transcranial magnetic stimulation].
Recent data suggest that repetitive transcranial magnetic stimulation (rTMS) is effective in treating depressive symptoms to a lesser extent compared with classical electroconvulsive therapy. However, rTMS represents an economical and well tolerable procedure in relation to the expenditure of electroconvulsive therapy with anaesthesia. Usually, rTMS is applicated as an add-on-therapy accompanying psychopharmacological treatment. So far, it has predominantly been used for patients with long-standing and so called treatment-refractory symptoms. However, even in the early phase of a depressive episode rTMS would be possibly more effective. In many cases, the standard procedure-application of up to 10 rTMS-sessions will not be enough to produce therapeutic benefit. Therefore rTMS series including up to 20 sessions are recommended. Long-term studies are needed to clarify the role of rTMS for relapse prevention and to determine the optimal frequency and duration of rTMS in such an indication. Although numerous results of newer studies suggest a moderate antidepressive effect of rTMS, its application in daily clinical routine practice cannot be recommended yet. Larger, accurate designed and controlled studies, especially involving patients of old age, are needed to evaluate the true tolerability and effectiveness of rTMS as a new treatment option for depressive symptoms.
Cordes
J
J
Klinik und Poliklinik für Psychiatrie und Psychotherapie der Heinrich-Heine-Universität Düsseldorf. cordes@uni-duesseldorf.de
Mobascher
A
A
Arends
M
M
Agelink
M W
MW
Klimke
A
A
D000328:Adult; D000368:Aged; D003863:Depression / Q000517:prevention & control / Q000628:therapy*; D004599:Electric Stimulation Therapy; D004565:Electroconvulsive Therapy / Q000191:economics; D004569:Electroencephalography; D004574:Electromagnetic Fields; D055590:Electromagnetic Phenomena / Q000379:methods; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D012449:Safety; D013997:Time Factors; D050781:Transcranial Magnetic Stimulation / Q000009:adverse effects / Q000627:therapeutic use*